Stay updated on Oral Semaglutide vs Sitagliptin in Diabetes Clinical Trial

Sign up to get notified when there's something new on the Oral Semaglutide vs Sitagliptin in Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Semaglutide vs Sitagliptin in Diabetes Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added; Revision: v3.4.2 removed.
    Difference
    0.0%
    Check dated 2026-03-12T14:42:49.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 in place of Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-12T01:46:29.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision indicators were updated from v3.4.0 to v3.4.1. This appears to be an administrative version control change and does not affect study content or functionality.
    Difference
    0.0%
    Check dated 2026-02-04T23:56:08.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added a 'Show glossary' feature, updated capitalization for QC-related labels, and introduced revision tag v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T21:20:13.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed (a minor metadata update that does not affect page content or functionality). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:59:14.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing all study sites (Arizona, California, Florida, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Maryland, Michigan, Montana, Nevada, New Mexico, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, and São Paulo) and removed the individual location pages (Arizona Locations, California Locations, etc.). Updated the revision to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T21:16:59.000Z thumbnail image

Stay in the know with updates to Oral Semaglutide vs Sitagliptin in Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Semaglutide vs Sitagliptin in Diabetes Clinical Trial page.